AI-generated summary
This Spanish Psoriasis Group consensus statement reviews narrowband UV-B therapy, excimer laser, and photodynamic therapy for psoriasis. The authors report that narrowband UV-B is currently considered the phototherapy option of choice because of its risk-to-benefit ratio, while excimer laser and photodynamic therapy are mainly used for localized and recalcitrant forms and are available in few Spanish centers. The abstract gives no participant or study counts.
- Who or what was studied
- Patients with psoriasis, particularly moderate to severe and localized or recalcitrant forms
- Limits stated in the abstract
- The abstract describes a consensus statement and does not report specific study data, sample sizes, or quantitative outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Photodynamic therapy, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.